VACCINES AGAINST HPV Russian patent published in 2018 - IPC C07K14/25 C07K14/52 C07K16/00 C07K16/44 C12N15/37 C12N15/63 A61K39/12 C12N5/10 A61P35/00 

Abstract RU 2644201 C2

FIELD: medicine.

SUBSTANCE: nucleic acid molecule encodes a homodimeric protein from two identical amino acid chains, each of which includes: (1) a signal peptide, (2) a directing unit, (3) a dimerization motif, and (4) an antigenic unit. The said directing unit consists of an amino acid sequence having at least 80% sequence identity with amino acid sequence 24-93 of SEQ ID NO: 1. The said antigenic unit includes an amino acid sequence derived from early human papillomavirus E6 (HPV16) and/or HPV18 proteins and an amino acid sequence derived from the early E7 protein from HPV16 and/or HPV18.

EFFECT: inventions allow to induce a specific and strong immune response to HPV by presenting APCs with the cells of immunogenic epitopes of HPV genes products and can be used as therapeutic compounds in treatment of various diseases caused by HPV, such as cancers and infectious diseases.

25 cl, 6 dwg, 4 ex

Similar patents RU2644201C2

Title Year Author Number
VACCINE COMPOSITION APPLICABLE IN HPV AND HEPATITIS VIRUS INFECTIONS, AND METHOD FOR PREPARING IT 2009
  • Ehlla Krishna Murtkhi
  • Sumatkhi Kandasvami
RU2509570C2
CPG AMPHIPHILES AND APPLICATIONS THEREOF 2019
  • Demuth, Peter, C.
  • Steinbuck, Martin
RU2823677C2
COMPOSITION COMPRISING LACTIC ACID BACTERIA, AN ORAL PHARMACEUTICAL COMPOSITION FOR TREATING HPV INFECTION AND/OR HPV-ASSOCIATED TUMORS AND AN AGENT INDUCING MUCOSAL IMMUNITY 2016
  • Kawana, Kei
  • Igimi, Shizunobu
RU2728788C2
HOMODIMER PROTEIN CONSTRUCTION 2011
  • Ruffini Per Adelki
  • Bogen Byarne
  • Fredriksen Agnete Brunsvik
RU2624041C2
NUCLEIC ACID MOLECULE ENCODING HPV 31 L1, EXPRESSION VECTOR, HOST CELL, VIRUS-LIKE PARTICLE AND METHOD OF ITS OBTAINMENT, VACCINE, PHARMACEUTICAL COMPOSITION AND METHODS INVOLVING THEM 2004
  • Jansen Katrin U.
  • Shul'Ts Loren D.
  • Niper Majkl P.
  • Markus Genri Z.
RU2356943C2
FUSION PROTEINS FOR APPLICATION AS IMMUNOGENIC AMPLIFYING AGENTS TO INDUCE ANTIGEN-SPECIFIC T-CELL RESPONSE 2013
  • U Chia-Mao
  • Chan Siu-Kan
RU2631002C2
OPTIMISED EXPRESSION LI HPV45 IN YEAST 2004
  • Brajan Dzhanin T.
  • Braunlou Mishell K.
  • Shul'Tts Loren D.
  • Jansen Katrin U.
RU2360001C2
VECTORS FOR MULTIPLE GENE EXPRESSION 2008
  • Sil'Vestr Natali
  • Shmitt Doris
RU2462513C2
OPTIMISED EXPRESSION OF HPV 58 L1 IN YEAST 2004
  • Brajan Dzhanin T.
  • Braunlou Mishell K.
  • Shul'Ts Loren D.
  • Van Sin'-Min'
  • Jansen Katrin U.
RU2370538C2
RECOMBINANT VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION AND METHOD OF ITS PREPARATION 2014
  • Krymskij Mikhail Aleksandrovich
  • Borisov Ivan Andreevich
  • Jakovlev Mikhail Simeonovich
  • Mel'Nikov Vladimir Alekseevich
RU2546243C1

RU 2 644 201 C2

Authors

Brekke Ule Khenrik

Fredriksen Agnete Brunsvik

Areffard Ali

Lindeberg Mona Mari

Dates

2018-02-08Published

2012-12-20Filed